医学
前列腺癌
肿瘤科
内科学
弹道
回顾性队列研究
癌症
放射性配体
化疗
梅德林
疾病
前列腺特异性抗原
耐火材料(行星科学)
转移
临床研究阶段
奥拉帕尼
实体瘤
作者
Frédéric Pouliot,Michele Lodde,Marjorie Besançon,Vincent Castonguay,Antoine Morin-Coulombe,Vincent Fradet,Yves Marie Fradet,L. Lacombe,Éric Lévesque,Nicolas Marcoux,Paul Toren,Geneviève April,Frédéric Arsenault,Alexis Beaulieu,Narcisse Ulrich Singbo,Céline Veilleux,Melanie Tremblay-Boily,Vincent Tremblay,François-Alexandre Buteau,Jean‐Mathieu Beauregard
摘要
Real-world data show that use of lutetium-177-PSMA-617 in patients with mCRPC is feasible in a universal healthcare system, with comparable oncologic activity to that observed in the phase 3 VISION trial. The study is limited by the short followup and its retrospective nature.
科研通智能强力驱动
Strongly Powered by AbleSci AI